AC Immune to discontinue development of ACI-91 small molecule

Français 178 KB Deutsch 178.8 KB Phase II results do not demonstrate efficacy of ACI-91 in patients with advanced Alzheimer's disease ACI-91 drug in-licensed with different mode-of-action from in-house therapies under development

The release as fetched from its publisher. acimmune.com ↗